Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Today Sponge

This article was originally published in The Tan Sheet

Executive Summary

OTC Drug Facts labeling for contraceptive sponge approved by FDA Nov. 3; packaging was last updated in 1994, Allendale Pharmaceuticals says. Agency has all information on stability tests, drug chemistry needed to make a decision on approval. The firm hopes to hear from FDA by the end of February. The Sponge has been available in Canada since March 2003 (1"The Tan Sheet" March 10, 2003, In Brief)...

You may also be interested in...



Today Sponge FDA Approval May Be “Just Weeks Away” – Firm

FDA is currently reviewing Canadian safety data on Allendale Pharmaceuticals' Today Sponge vaginal contraceptive, according to the firm

Today Sponge in Canada

First shipment of contraceptive devices to Canada is underway after nearly $1 mil. in investments to meet GMP standards, according to Allendale Pharmaceuticals. Canadian brick-and-mortar retailers such as Wal-Mart, Shoppers Drug Mart, PharmaPlus should have Today Sponge by April 1, while three online retailers were expected to begin selling product March 1, Allendale says. Firm anticipates it is still roughly nine months away from U.S. distribution, as it has yet to complete six-month stability studies and host FDA plant inspection...

US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising

US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS097500

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel